JOURNAL OF THE CZECH PEDIATRIC SOCIETY AND THE SLOVAK PEDIATRIC SOCIETY

Čes-slov Pediat 2024, 79(88):9-12 | DOI: 10.55095/CSPediatrie2024/027

Meningococcal infections in childhoodComprehensive Report

Hana Roháčová
Klinika infekčních nemocí, Fakultní nemocnice Bulovka, Praha

Meningococcal infections count among the most dangerous infectious conditions that may affect humans regardless of their age. Anyway, the age groups at highest risk are children up to age 4 years, and adolescents. Adolescents are not only at risk of being infected but also to become source of infection for the contacts when serving as carriers of Neisseria meningitidis infection.

The incidence of meningoccal infections in the Czech Republic is not high. In 2023 there were 17 cases of invasive meningococcal diseases confirmed.(1) The spectrum of clinical expression is broad. The illnesses may be

divided into noninvasive and invasive. In invasive, their morality rate reaches 10% and severe sequelae 20%.(2) The only protection that can prevent illness is vaccination. Thera are now

vaccines available against serotypes A, C, W, Y, B.

Keywords: meningococcal infections, clinical course, therapy, contact protection

Accepted: May 7, 2024; Published: August 1, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Roháčová H. Meningococcal infections in childhood. Ces-slov Pediat. 2024;79(Suppl.1):9-12. doi: 10.55095/CSPediatrie2024/027.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Informační systém infekčních nemocí. Dostupné na: https://www.uzis.czWHO. Factsheet No. 141. 2015. Dostupné na: http://www.who.int/mediacentre/factsheets/fs141/en/
    2. CDC. Pinkbook: Meningococcal Disease. Dostupné na: https://www.cdc.gov/vaccines/pubs/pinkbook/mening.html
    3. Van Deuren M, et al. Clinical Microbiology Reviews. 2000: 144-166. Go to original source...
    4. Sabra A, Benger J. Meningococcal disease in children: a clinical review. Turk J Pediatr 2011; 53: 477-488.
    5. Národní referenční laboratoř pro meningokokové nákazy, Státní zdravotní ústav v Praze. Kumulativní surveillance dat IMO za období 2013-2022.
    6. Brouwer MC, Read RC, Van de Beek D. Host genetics and outcome in meningococcal disease: a systematic review and meta-analysis. Lancet Infect Dis 2010; 10: 262-274. Go to original source... Go to PubMed...
    7. Křížová P. Med praxi 2020; 17(5): 317-320.
    8. Sadarangani, et al. Clin Infect Dis 2015; 60: e27-35. Go to original source... Go to PubMed...
    9. Gammelgaard LK, Colding H, Hartzen SH, et al. Meningococcal disease and future drug targets, CNS Neurol Disord Drug Targets 2011; 10: 140-145. Go to original source... Go to PubMed...
    10. WHO. Factsheet. Dostupné na: https://www.who.int/news-room/fact-sheets/detail/meningitis
    11. Hamborsky, et al. Epidemiology and prevention of vaccine-preventable diseases. 14th ed. 2015: 331-46.

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content